| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 03/01/2011 | US7897384 Chondrocyte therapeutic delivery system |
| 03/01/2011 | US7897351 Peptides and antibodies to MUC 1 proteins |
| 03/01/2011 | US7897346 Polyamide nucleic acid derivatives and agents, and processes for preparing them |
| 03/01/2011 | US7897152 Viral chemokine-antigen fusion proteins |
| 03/01/2011 | CA2677068A1 Nucleic acid compounds for inhibiting gene expression and uses thereof |
| 03/01/2011 | CA2469154C Cytotoxic protein and utilization thereof |
| 03/01/2011 | CA2411660C Enzyme-cleavable prodrug compounds |
| 03/01/2011 | CA2396590C 2-amino-nicotinamide derivatives and their use as vegf-receptor tyrosine kinase inhibitors |
| 03/01/2011 | CA2368618C Method of enhancing the efficacy of anti-tumor agents |
| 03/01/2011 | CA2348488C Novel agents and methods for treatment and diagnosis of ocular disorders |
| 03/01/2011 | CA2339331C Expression and export of angiogenesis inhibitors as immunofusins |
| 03/01/2011 | CA2323525C Therapeutic and diagnostic applications based on the role of the cxcr-4 gene in tumorigenesis |
| 02/24/2011 | WO2011022694A2 Furanopyrimidine cannabinoid compounds and related methods of use |
| 02/24/2011 | WO2011022692A2 Furanopyridine cannabinoid compounds and related methods of use |
| 02/24/2011 | WO2011022679A2 Benzofuran cannabinoid compounds and related methods of use |
| 02/24/2011 | WO2011022509A2 Substituted benzoazepines as toll-like receptor modulators |
| 02/24/2011 | WO2011022508A2 Substituted benzoazepines as toll-like receptor modulators |
| 02/24/2011 | WO2011022489A2 (bis) urea and (bis) thiourea compounds as epigenic modulators of lysine-specific demethylase 1 and methods of treating disorders |
| 02/24/2011 | WO2011022264A1 Anti-angiogenesis therapy for the treatment of previously treated breast cancer |
| 02/24/2011 | WO2011022056A2 PEPTIDE MODULATORS OF THE δPKC INTERACTION WITH THE D SUBUNIT OF F1FO ATP SYNTHASE/ATPASE AND USES THEREOF |
| 02/24/2011 | WO2011021864A2 Novel compound for complementing anticancer drugs, a production method for the same, a composition for complementing anticancer drugs comprising the same, and a method for reducing resistance to anticancer drugs using the same |
| 02/24/2011 | WO2011021678A1 Fused heterocyclic compound |
| 02/24/2011 | WO2011021597A1 Quinoline derivative-containing pharmaceutical composition |
| 02/24/2011 | WO2011021524A1 Peptides inducing adhesive property of lactic acid bacterium and use of same |
| 02/24/2011 | WO2011021503A1 Pharmaceutical composition containing transiently surviving ctl |
| 02/24/2011 | WO2011021397A1 Colchicine derivatives |
| 02/24/2011 | WO2011021386A1 Cstf2 for target genes of lung cancer therapy and diagnosis |
| 02/24/2011 | WO2011021381A1 Pharmaceutical composition containing anti-hb-egf antibody as active ingredient |
| 02/24/2011 | WO2011021212A1 Methods of treating drug resistant and other tumors with 6,7-dialkoxy quinazoline derivatives |
| 02/24/2011 | WO2011021209A1 Histone deacetylase inhibitors |
| 02/24/2011 | WO2011021038A1 Tricyclic heterocyclic compounds as phosphoinositide 3-kinase inhibitors |
| 02/24/2011 | WO2011020861A1 Heterocyclic oxime compounds |
| 02/24/2011 | WO2011020615A1 Novel fxr (nr1h4 ) binding and activity modulating compounds |
| 02/24/2011 | WO2011020294A1 Magnetic nanoparticles having novel core-shell structure and ph responsiveness, and use thereof |
| 02/24/2011 | WO2011020288A1 Substituted hydrazide compounds and application thereof |
| 02/24/2011 | WO2011001122A3 Pyrazole derivatives, preparation thereof, and therapeutic use thereof |
| 02/24/2011 | WO2011001113A3 Novel 1,2,3,4-tetrahydro-pyrimido(1,2-a)pyrimidin-6-one derivatives, preparation thereof, and pharmaceutical use thereof |
| 02/24/2011 | WO2010149944A8 Indolyl-substituted pyrazino-quinolines and their use for the treatment of cancer |
| 02/24/2011 | WO2010125462A4 Pentamidine combinations for treating cancer |
| 02/24/2011 | WO2010121675A3 Thiazolyl-benzimidazoles |
| 02/24/2011 | WO2010121164A3 1,4-benzodiazepinone compounds and their use in treating cancer |
| 02/24/2011 | WO2010120942A3 Histone modification patterns for clinical diagnosis and prognosis of cancer |
| 02/24/2011 | WO2010117992A3 Coupled identification and treatment of cancer |
| 02/24/2011 | WO2010107909A3 Methods and compositions for the detection of cancer |
| 02/24/2011 | WO2010104749A3 Antigen presenting cell targeted cancer vaccines |
| 02/24/2011 | WO2010104588A3 Compositions and methods for characterizing and treating neoplasia |
| 02/24/2011 | WO2010096719A3 Anticancer and antimicrobial compounds from antarctic extremophilic microorganisms |
| 02/24/2011 | WO2010095879A3 Sirna to be bound to transcripts of apoptosis-related genes, and compositions for treating cancer using same |
| 02/24/2011 | WO2010080769A4 Chemotherapeutic methods and compositions |
| 02/24/2011 | WO2010077663A3 Substituted tetracyclic 1h-indeno (1,2-b) pyridine-2 (5h)-one analogs thereof and uses thereof |
| 02/24/2011 | WO2010039997A3 Hematopoietic protection against chemotherapeutic compounds using selective cyclin-dependent kinase 4/6 inhibitors |
| 02/24/2011 | WO2010028780A3 Preparation and uses of guanidinium-modified porphyrins and phthalocyanines |
| 02/24/2011 | US20110047631 Heat shock protein deficiencies as model systems for brain pathology and cancer |
| 02/24/2011 | US20110047103 Anti-angiogenesis therapy for the treatment of previously treated breast cancer |
| 02/24/2011 | US20110046606 Catheter injectable depot compositions and uses thereof |
| 02/24/2011 | US20110046237 Compounds with activity at estrogen receptors |
| 02/24/2011 | US20110046235 Products comprising, and uses of, decarboxylated phenolic acids derived from chlorogenic acids of coffee |
| 02/24/2011 | US20110046234 Retinaldehyde in the Treatment of Obesity, Diabetes and Other Conditions |
| 02/24/2011 | US20110046233 Gossypol derivatives, production method thereof and uses of same |
| 02/24/2011 | US20110046211 Combination therapy of hedgehog inhibitors, radiation and chemotherapeutic agents |
| 02/24/2011 | US20110046210 Substituted thiopenecarboxamides as ikk-beta serine-, threonine-protein kinase inhibitors |
| 02/24/2011 | US20110046209 RNA-Induced Translational Silencing and Cellular Apoptosis |
| 02/24/2011 | US20110046204 Human Zip1, Zinc and Citrate for Prostate Cancer Screening |
| 02/24/2011 | US20110046197 3-aminocarbazole compounds, pharmaceutical composition containing the same and method for the preparation thereof |
| 02/24/2011 | US20110046190 Combinations comprising a selective cyclooxygenase-2 inhibitor |
| 02/24/2011 | US20110046189 Heteroaryl-substituted bicyclic smac mimetics and the uses thereof |
| 02/24/2011 | US20110046183 Crystal of benzimidazole compound |
| 02/24/2011 | US20110046182 Efficient aspirin prodrugs |
| 02/24/2011 | US20110046176 Furanopyridine cannabinoid compounds and related methods of use |
| 02/24/2011 | US20110046175 Benzofuran cannabinoid compounds and related methods of use |
| 02/24/2011 | US20110046170 Novel pyrimidine-pyridine derivatives |
| 02/24/2011 | US20110046169 Fused heterocyclic derivatives and use thereof |
| 02/24/2011 | US20110046168 Methods of treating diseases using quinazoline derivatives and pharmaceutical compositions containing them |
| 02/24/2011 | US20110046167 Acyclic amine inhibitors of 5-methytioadenosine phosphorylase and nucleosidase |
| 02/24/2011 | US20110046165 Certain chemical entitles, compositions and methods |
| 02/24/2011 | US20110046163 Furanopyrimidine cannabinoid compounds and related methods of use |
| 02/24/2011 | US20110046157 Substituted hydroxamic acids and uses thereof |
| 02/24/2011 | US20110046155 Hydrobenzamide derivatives as inhibitors of hsp90 |
| 02/24/2011 | US20110046154 Use of aminopeptidase inhibitors or azaindole compounds for preventing or treating cancerous metastases from epithelial origin |
| 02/24/2011 | US20110046147 17beta-hydroxysteroid dehydrogenase type 1 inhibitors for the treatment of hormone-related diseases |
| 02/24/2011 | US20110046144 Imidazopyrazinol derivatives for the treatment of cancers |
| 02/24/2011 | US20110046143 Disubstituted phthalazine hedgehog pathway antagonists |
| 02/24/2011 | US20110046131 Purines as pkc-theta inhibitors |
| 02/24/2011 | US20110046127 Imidazopyridazines for Use as Protein Kinase Inhibitors |
| 02/24/2011 | US20110046122 3-amino-5-phenyl-5,6-dihydro-2h-[1,4]oxazines |
| 02/24/2011 | US20110046113 Amine compound and use thereof |
| 02/24/2011 | US20110046111 Quinazoline linked pyrrolo[2,1-c][1, 4]benzodiazepine hybrids as potential anticancer agents and process for the preparation thereof |
| 02/24/2011 | US20110046109 2,4,8-trisubstituted-8h-pyrido[2,3-d]pyrimidin-7-one compounds and compositions for use in therapy |
| 02/24/2011 | US20110046108 Pyrimidine derivatives |
| 02/24/2011 | US20110046100 Texaphyrin solutions and pharmaceutical formulations |
| 02/24/2011 | US20110046098 Progesterone antagonists such as cdb-4124 in the treatment of endometriosis, uterine fibroids, dysmenorrhea, breast cancer, etc. |
| 02/24/2011 | US20110046097 Substituted indolin-2-one derivatives and their use as p38 mitogen-activated kinase inhibitors |
| 02/24/2011 | US20110046093 Pyrimidine derivatives as protein kinase inhibitors |
| 02/24/2011 | US20110046086 Composition Comprising Polysaccharide Extracted from Panax Ginseng Preventing and Treating Liver Diseases |
| 02/24/2011 | US20110046083 Activators of pyruvate kinase m2 and methods of treating disease |
| 02/24/2011 | US20110046078 Methods and compositions for treating diseases and disorders associated with siglec-8 |
| 02/24/2011 | US20110046071 GLP-1 Receptor Agonists And Related Active Pharmaceutical Ingredients For Treatment Of Cancer |
| 02/24/2011 | US20110046070 Gene expression inhibitor selective for matrix metalloproteinase-9 gene |
| 02/24/2011 | US20110046069 Uses of Modified ELR-CXC Chemokine G31P |
| 02/24/2011 | US20110046068 Compound, Use and Method |